Clinical Trial Update: EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

Clinical trial update for EndoBarrier in obese subjects with type 2 diabetes; the study has completed and results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• EndoBarrier (duodenal-jejunal bypass liner)

Snippet

Sponsor: Medical University of Graz | Conditions: Type 2 Diabetes, Obesity | NA | Status: COMPLETED | Results posted: 2024-04-08